Figure][1] Jason S. Lewis, PhD Professor Jason S. Lewis holds the Emily Tow Chair at Memorial Sloan Kettering (MSK) in New York. He serves as deputy director of the Sloan Kettering Institute, ...
Molecularly targeted therapies are increasingly relevant in clinical oncology, as they enable the selective modulation of specific biologic targets—such as enzymes or receptors—by inhibiting or ...
Incidental findings from PET are common, induce unnecessary patient anxiety, and incur substantial costs to the health care system, with further diagnostic clarification potentially delaying important ...
The second Society of Nuclear Medicine and Molecular Imaging (SNMMI) AI Summit, organized by the SNMMI AI Task Force, took ...
Radiopharmaceuticals represent a promising new frontier in cancer therapy. In the United States, cancer is the second leading cause of death. There is an urgent need to develop new therapies to meet ...
The only research study on humans (3), using a tumor-optimized PET protocol, examined exclusively the pituitary, reporting nonsignificantly higher 18 F-fluoroestradiol (FES) uptake in postmenopausal ...
The level of evidence is consistently increasing: the ability of chatbots to mimic humans is impressive, even in the scientific and medical domains (1–3). The role they will play in the process of ...
A landmark study from the Institute of Medicine reported that the assessment of cognitive difficulties in children with epilepsy is timely and imperative. Anticonvulsant-induced cognitive impairment ...
The aim of this study was to prospectively compare whole-body PET/MR imaging and PET/CT, qualitatively and quantitatively, in oncologic patients and assess the confidence and degree of inter- and ...
Metal implants can significantly degrade the quality of CT images (1,2). Artifacts are visible on the images because of beam hardening, Compton scattering, and noise (1,3). This is especially of ...
The recently released Biograph mMR is the first commercially available integrated whole-body PET/MR scanner. There are considerable advantages to integrating both modalities in a single scanner that ...
The PSMA-targeting ligand 177 Lu-PSMA-617 was prepared in compliance with good manufacturing practices. Radio–high-performance liquid chromatography as the primary method of quality control was ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results